182 related articles for article (PubMed ID: 15879000)
41. Possible involvement of P-glycoprotein in renal excretion of pazufloxacin in rats.
Shimizu A; Miyoshi M; Sugie M; Ueyama J; Yamaguchi T; Sasaki T; Takagi K; Jin M; Miyamoto K; Tsuji A; Hasegawa T
Eur J Pharmacol; 2004 Oct; 501(1-3):151-9. PubMed ID: 15464074
[TBL] [Abstract][Full Text] [Related]
42. Uremic toxins adsorbed by AST-120 promote tubular hypertrophy and interstitial fibrosis in nephrectomized rats.
Okada K; Matsumoto K; Takahashi S
Kidney Blood Press Res; 2005; 28(1):8-13. PubMed ID: 15377820
[TBL] [Abstract][Full Text] [Related]
43. Lack of effect of P-glycoprotein inhibition on renal clearance of dicloxacillin in patients with cystic fibrosis.
Beringer PM; Kriengkauykiat J; Zhang X; Hidayat L; Liu S; Louie S; Synold T; Burckart GJ; Rao PA; Shapiro B; Gill M
Pharmacotherapy; 2008 Jul; 28(7):883-94. PubMed ID: 18576903
[TBL] [Abstract][Full Text] [Related]
44. Halofuginone reduces the occurrence of renal fibrosis in 5/6 nephrectomized rats.
Benchetrit S; Yarkoni S; Rathaus M; Pines M; Rashid G; Bernheim J; Bernheim J
Isr Med Assoc J; 2007 Jan; 9(1):30-4. PubMed ID: 17274353
[TBL] [Abstract][Full Text] [Related]
45. Administration of ghrelin to young uraemic rats increases food intake transiently, stimulates growth hormone secretion and does not improve longitudinal growth.
Alvarez-García O; García-López E; Rodríguez J; Gil-Peña H; Molinos I; Carbajo-Pérez E; Santos F
Nephrol Dial Transplant; 2007 May; 22(5):1309-13. PubMed ID: 17317714
[TBL] [Abstract][Full Text] [Related]
46. Chronic inhibition of NOS-2 ameliorates renal injury, as well as COX-2 and TGF-beta 1 overexpression in 5/6 nephrectomized rats.
Bautista-García P; Sánchez-Lozada LG; Cristóbal-García M; Tapia E; Soto V; Avila-Casado MC; Márquez-Velasco R; Bojalil R; Franco M; Herrera-Acosta J
Nephrol Dial Transplant; 2006 Nov; 21(11):3074-81. PubMed ID: 16935907
[TBL] [Abstract][Full Text] [Related]
47. The influence of chronic renal failure on drug metabolism and transport.
Dreisbach AW
Clin Pharmacol Ther; 2009 Nov; 86(5):553-6. PubMed ID: 19776735
[TBL] [Abstract][Full Text] [Related]
48. Glucagon metabolism in the rat.
Emmanouel DS; Jaspan JB; Rubenstein AH; Huen AH; Fink E; Katz AI
J Clin Invest; 1978 Jul; 62(1):6-13. PubMed ID: 659638
[TBL] [Abstract][Full Text] [Related]
49. Roles of organic anion transporters in the renal excretion of perfluorooctanoic acid.
Nakagawa H; Hirata T; Terada T; Jutabha P; Miura D; Harada KH; Inoue K; Anzai N; Endou H; Inui K; Kanai Y; Koizumi A
Basic Clin Pharmacol Toxicol; 2008 Jul; 103(1):1-8. PubMed ID: 18373647
[TBL] [Abstract][Full Text] [Related]
50. Effects of uremic toxins on hepatic uptake and metabolism of erythromycin.
Sun H; Huang Y; Frassetto L; Benet LZ
Drug Metab Dispos; 2004 Nov; 32(11):1239-46. PubMed ID: 15286055
[TBL] [Abstract][Full Text] [Related]
51. Probenecid, an inhibitor of transmembrane organic anion transporters, alters tissue distribution of DNA adducts in 1-hydroxymethylpyrene-treated rats.
Monien BH; Müller C; Bakhiya N; Donath C; Frank H; Seidel A; Glatt H
Toxicology; 2009 Jul; 262(1):80-5. PubMed ID: 19481134
[TBL] [Abstract][Full Text] [Related]
52. Expression of rat renal cortical OAT1 and OAT3 in response to acute biliary obstruction.
Brandoni A; Villar SR; Picena JC; Anzai N; Endou H; Torres AM
Hepatology; 2006 May; 43(5):1092-100. PubMed ID: 16628676
[TBL] [Abstract][Full Text] [Related]
53. A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters.
Tahara H; Kusuhara H; Endou H; Koepsell H; Imaoka T; Fuse E; Sugiyama Y
J Pharmacol Exp Ther; 2005 Oct; 315(1):337-45. PubMed ID: 16006492
[TBL] [Abstract][Full Text] [Related]
54. Secretory activity and aryl acid content of serum, urine, and cerebrospinal fluid in normal and uremic man.
Porter RD; Cathcart-Rake WF; Wan SH; Whittier FC; Grantham JJ
J Lab Clin Med; 1975 May; 85(5):723-31. PubMed ID: 1168235
[TBL] [Abstract][Full Text] [Related]
55. Physiologically based pharmacokinetic model for the renal clearance of salicyluric acid and the interaction with phenolsulfonphthalein in the dog.
Russel FG; Wouterse AC; van Ginneken CA
Drug Metab Dispos; 1987; 15(5):695-701. PubMed ID: 2891488
[TBL] [Abstract][Full Text] [Related]
56. Renal failure in high altitude: renal functions, renal pathology and bone mineralization in rats with ablation nephropathy at 1200 m altitude.
Soylu A; Kavukçu S; Yilmaz O; Astarcioğlu H; Ozkal S; Türkmen M; Sarioğlu S
Pathol Res Pract; 2007; 203(11):795-800. PubMed ID: 17904299
[TBL] [Abstract][Full Text] [Related]
57. Variability in renal clearance of substrates for renal transporters in chinese subjects.
Yin OQ; Tomlinson B; Chow MS
J Clin Pharmacol; 2006 Feb; 46(2):157-63. PubMed ID: 16432267
[TBL] [Abstract][Full Text] [Related]
58. Excretion of ofloxacin into saliva in rats with renal failure.
Ding G; Naora K; Nagasako S; Hirano H; Iwamoto K
J Pharmacol Exp Ther; 1998 Oct; 287(1):31-6. PubMed ID: 9765318
[TBL] [Abstract][Full Text] [Related]
59. Comparison of urinary excretion of phenolsulfonphthalein in an animal model for Wilson's disease (Long-Evans Cinnamon rats) with that in normal Wistar rats: involvement of primary active organic anion transporter.
Itagaki S; Shimamoto S; Hirano T; Iseki K; Sugawara M; Nishimura S; Fujimoto M; Kobayashi M; Miyazaki K
J Pharm Pharm Sci; 2004 Jul; 7(2):227-34. PubMed ID: 15367380
[TBL] [Abstract][Full Text] [Related]
60. Lineage-negative bone marrow cells protect against chronic renal failure.
Alexandre CS; Volpini RA; Shimizu MH; Sanches TR; Semedo P; di Jura VL; Câmara NO; Seguro AC; Andrade L
Stem Cells; 2009 Mar; 27(3):682-92. PubMed ID: 19096042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
